{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T03:06:32Z","timestamp":1780369592045,"version":"3.54.1"},"reference-count":85,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12_suppl_6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2002,12,24]]},"DOI":"10.1212\/wnl.59.12_suppl_6.s33","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T14:03:37Z","timestamp":1336917817000},"source":"Crossref","is-referenced-by-count":39,"title":["Intravenous gammaglobulin (IVIg) for treatment of CIDP and related immune-mediated neuropathies"],"prefix":"10.1212","volume":"59","author":[{"suffix":"III","given":"Thomas H.","family":"Brannagan","sequence":"first","affiliation":[{"name":"From the Peripheral Neuropathy Center, Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199204233261705"},{"key":"e_1_3_1_3_2","doi-asserted-by":"crossref","unstructured":"Hughes RA and the Plasma Exchange\/Sandoglobulin Guillain-Barr\u00e9 Syndrome Trial Group. Randomised trial of plasma exchange intravenous immunoglobulin and combined treatments in Guillain-Barr\u00e9 syndrome. Lancet 1997;349:225\u2013330.","DOI":"10.1016\/S0140-6736(96)09095-2"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/119.4.1067"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.4.445"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410360607"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.59.3.248"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1995.tb00150.x"},{"key":"e_1_3_1_9_2","first-page":"699.","volume":"60","year":"1996","unstructured":"Molina JA, Benito-Leon J, Bermejo F, Jimenez-Jimenez FJ, Olivan J. Intravenous immunoglobulin therapy in sensory neuropathy associated with Sj\u00f6gren\u2019s syndrome. J Neurol Neurosurg Psychiatry . 1996; 60: 699.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_3_1_10_2","first-page":"766","volume":"9","year":"2002","unstructured":"Gorson KC, Ropper AH, Weinberg DH, Weinstein R. Efficacy of intravenous immunoglobulin in patients with IgG monoclonal gammopathy and polyneuropathy. Arch Neurol . 2002; 9: 766\u2013772.","journal-title":"Arch Neurol"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1990.03450240091046"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(199603)19:3<388::AID-MUS20>3.0.CO;2-N"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.3.674"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-121-4-199408150-00004"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.9.1699"},{"key":"e_1_3_1_16_2","first-page":"35","volume":"78","year":"1993","unstructured":"Schiavotto C, Ruggeri M, Rodeghiero F. Adverse reactions after high-dose intravenous immunoglobulin: incidence in 83 patients treated for idiopathic thrombocytopenic purpura (ITP) and review of the literature. Haematologica Suppl . 1993; 78: 35\u201340.","journal-title":"Haematologica Suppl"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(199911)22:11<1479::AID-MUS3>3.0.CO;2-B"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199201093260206"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)90563-V"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/1096-8652(200009)65:1<30::AID-AJH5>3.0.CO;2-J"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.48.2.321"},{"key":"e_1_3_1_22_2","first-page":"127","volume":"51","year":"1999","unstructured":"Kubori T, Mezaki T, Kaji R, et al. The clinical usefulness of high dose intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy. No To Shinkei . 1999; 51: 127\u2013135.","journal-title":"No To Shinkei"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199106063242305"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.1088"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1991.00530140113024"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.66.6.727"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(86)90296-2"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198810063191403"},{"key":"e_1_3_1_29_2","first-page":"254","volume":"9","year":"1993","unstructured":"Misbah SA, Chapel HM. Adverse effects of intravenous immunoglobulin. Drug Experience . 1993; 9: 254\u2013262.","journal-title":"Drug Experience"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1006\/clin.1994.1136"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.5.1856.005k03_1856_1861"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-126-9-199705010-00008"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198602273140907"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006650812886"},{"key":"e_1_3_1_35_2","unstructured":"Kobayashi   RH Stiehm   ER.   Immunoglobulin therapy.  In:  Petz  LD Swisher  SN eds.  Clinical practice of transfusion medicine.   New York:   Churchill Livingstone 1995:  985\u20131010."},{"key":"e_1_3_1_36_2","first-page":"376.","volume":"232","year":"1992","unstructured":"Donatini B. Transient renal dysfunction in diabetic patients after IVIg therapy. J Intern Med . 1992; 232: 376.Letter.","journal-title":"J Intern Med"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90110-0"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199210013271416"},{"key":"e_1_3_1_39_2","first-page":"518","volume":"48","year":"1999","unstructured":"Center for Disease Control and Prevention. Renal insufficiency and failure associated with immune globulin intravenous therapy-United States, 1985\u20131998. MMWR . 1999; 48: 518\u2013521.","journal-title":"MMWR"},{"key":"e_1_3_1_40_2","doi-asserted-by":"crossref","unstructured":"Tan E Hajinazarian M Bay W Neff J Mendell JR. Acute renal failure resulting from intravenous immunoglobulin therapy. Arch Neurol 1993;50:137\u2013139.","DOI":"10.1001\/archneur.1993.00540020015010"},{"key":"e_1_3_1_41_2","first-page":"S53","volume":"14","year":"1996","unstructured":"Nydegger UE. Safety and side effects of IV immunoglobulin therapy. Clin Exp Rheumatol . 1996; 14 (suppl 15): S53\u201357.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_1_42_2","first-page":"1141.","volume":"295","year":"1987","unstructured":"Barucha C, McMillan JC. Eczema after intravenous infusion of immunoglobulin. BMJ . 1987; 295: 1141.Letter.","journal-title":"BMJ"},{"key":"e_1_3_1_43_2","first-page":"1436.","volume":"2","year":"1987","unstructured":"Chan-Lam D, Fitzsimons EJ, Douglas WS. Alopecia after immunoglobulin infusion. Lancet . 1987; 2: 1436.Letter.","journal-title":"Lancet"},{"key":"e_1_3_1_44_2","first-page":"1291.","volume":"317","year":"1998","unstructured":"Howse M, Bindoff L, Carmichael A. Facial vasculitic rash associated with intravenous immunoglobulin. BMJ . 1998; 317: 1291.","journal-title":"BMJ"},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2000.163"},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)70844-X"},{"key":"e_1_3_1_47_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.59.1.77"},{"key":"e_1_3_1_48_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.38"},{"key":"e_1_3_1_49_2","first-page":"217","volume":"2","year":"1986","unstructured":"Woodruff RK, Grigg AP, Firkin FC, Smith IL. Fatal thrombotic events during treatment of autoimmune thrombocytopenia with intravenous immunoglobulin in elderly patients. Lancet . 1986; 2: 217\u2013218.","journal-title":"Lancet"},{"key":"e_1_3_1_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)90806-E"},{"key":"e_1_3_1_51_2","first-page":"775","volume":"13","year":"1997","unstructured":"Fisman DN, Smilovitch M. Intravenous immunoglobulin, blood viscosity and myocardial infarction. Can J Cardiol . 1997; 13: 775\u2013777.","journal-title":"Can J Cardiol"},{"key":"e_1_3_1_52_2","doi-asserted-by":"publisher","DOI":"10.1002\/1096-8652(200010)65:2<177::AID-AJH17>3.0.CO;2-K"},{"key":"e_1_3_1_53_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1992.00530330103025"},{"key":"e_1_3_1_54_2","doi-asserted-by":"publisher","DOI":"10.1177\/000331970205300117"},{"key":"e_1_3_1_55_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.1.257"},{"key":"e_1_3_1_56_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.6.1180"},{"key":"e_1_3_1_57_2","first-page":"79","volume":"68","year":"2000","unstructured":"Turner B, Wills AJ. Cerebral infarction complicating intravenous immunoglobulin therapy in a patient with Miller Fisher syndrome. J Neurol Neurosurg Psychiatry . 2000; 68: 79\u201391.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_3_1_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0248-8663(99)80064-2"},{"key":"e_1_3_1_59_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.2.223"},{"key":"e_1_3_1_60_2","doi-asserted-by":"publisher","DOI":"10.4065\/75.1.83"},{"key":"e_1_3_1_61_2","doi-asserted-by":"publisher","DOI":"10.1177\/014107680109400412"},{"key":"e_1_3_1_62_2","first-page":"A54.","volume":"48","year":"1997","unstructured":"Haplea SS, Farrar JT, Gibson GA, Laskin M, Pizzi LT, Asbury AK. Thromboembolic events associated with intravenous immunoglobulin therapy. Neurology . 1997; 48: A54.Abstract.","journal-title":"Neurology"},{"key":"e_1_3_1_63_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.43.26473"},{"key":"e_1_3_1_64_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.60.5.586"},{"key":"e_1_3_1_65_2","first-page":"347","volume":"98","year":"1998","unstructured":"Mathy I, Gille M, van Raemdonck F, Delbecq J, Depr\u00e9 A. Neurological complications of intravenous immunoglobulin (IVIg) therapy: an illustrative case of acute encephalopathy following IVIg therapy and a review of the literature. Acta Neurol Belg . 1998; 98: 347\u2013351.","journal-title":"Acta Neurol Belg"},{"key":"e_1_3_1_66_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.46.1.250"},{"key":"e_1_3_1_67_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199308193290820"},{"key":"e_1_3_1_68_2","doi-asserted-by":"publisher","DOI":"10.1093\/clind\/15.3.560"},{"key":"e_1_3_1_69_2","first-page":"1636","volume":"42","year":"1992","unstructured":"Vera-Ramirez M, Charlet M, Parry GJ. Recurrent aseptic meningitis complicating intravenous immunoglobulin therapy for CIDP. Neurology . 1992; 42: 1636\u20131637.","journal-title":"Neurology"},{"key":"e_1_3_1_70_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(199709)20:9<1102::AID-MUS2>3.0.CO;2-C"},{"key":"e_1_3_1_71_2","first-page":"270","volume":"326","year":"1991","unstructured":"Ben-Chetrit E, Putterman C. Transient neutropenia induced by intravenous immune globulin. N Engl J Med . 1991; 326: 270\u2013271. Letter.","journal-title":"N Engl J Med"},{"key":"e_1_3_1_72_2","first-page":"1262.","volume":"296","year":"1988","unstructured":"Majer RV, Green PJ. Neutropenia caused by intravenous immunoglobulin. BMJ . 1988; 296: 1262.Letter.","journal-title":"BMJ"},{"key":"e_1_3_1_73_2","first-page":"291.","volume":"36","year":"1994","unstructured":"Bower LR, Brey RL, Rogers SJ, Stroncek DF, Jackson CE. Intravenous immunoglobulin-induced neutropenia. Ann Neurol . 1994; 36: 291.Abstract.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90112-4"},{"key":"e_1_3_1_75_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1989.tb136537.x"},{"key":"e_1_3_1_76_2","first-page":"231","volume":"35","year":"1986","unstructured":"Center for Disease Control and Prevention. Safety of therapeutic immune globulin preparations with respect to transmission of human t-lymphotropic virus type III\/lymphadenopathy-associated virus infection. MMWR . 1986; 35: 231\u2013233.","journal-title":"MMWR"},{"key":"e_1_3_1_77_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1986.26486262753.x"},{"key":"e_1_3_1_78_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199412153312402"},{"key":"e_1_3_1_79_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199412153312409"},{"key":"e_1_3_1_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(95)00269-8"},{"key":"e_1_3_1_81_2","first-page":"558","volume":"339","year":"1992","unstructured":"Aycliffe W, Haeney M, Roberts SC, Lavin M. Uveitis after antineutrophil cytoplasmic antibody contamination of immunoglobulin replacement therapy. Lancet . 1992; 339: 558\u2013559.","journal-title":"Lancet"},{"key":"e_1_3_1_82_2","first-page":"1175","volume":"339","year":"1992","unstructured":"Donatini B, Goetz J, Hauptmann G. Uveitis and antineutrophil cytoplasmic antibody in immunoglobulin batches. Lancet . 1992; 339: 1175\u20131176.","journal-title":"Lancet"},{"key":"e_1_3_1_83_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/16.2.403"},{"key":"e_1_3_1_84_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2001.41020264.x"},{"key":"e_1_3_1_85_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199705000-00004"},{"key":"e_1_3_1_86_2","doi-asserted-by":"publisher","DOI":"10.1159\/000056085"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/full\/10.1212\/WNL.59.12_suppl_6.S33","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T15:59:28Z","timestamp":1711555168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.59.12_suppl_6.S33"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12,24]]},"references-count":85,"journal-issue":{"issue":"12_suppl_6","published-print":{"date-parts":[[2002,12,24]]}},"alternative-id":["10.1212\/WNL.59.12_suppl_6.S33"],"URL":"https:\/\/doi.org\/10.1212\/wnl.59.12_suppl_6.s33","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,12,24]]}}}